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Coronary calcium scoring: are the results
comparable to computed tomography coronary
angiography for screening coronary artery disease
in a South Asian population?
Nizar Bhulani1, Ali Khawaja2*, Asif Jafferani3, Maryam Baqir2, Ramin Ebrahimi4 and Zafar Sajjad5
Abstract
Background: The need of having feasible screening tools like Coronary Calcium Scoring (CCS) and CT Coronary
Artery (CTCA) for Coronary Artery Disease (CAD) has become paramount. We aimed to evaluate the accuracy of
CCS in determining the degree of stenosis of coronary vessels as compared to that determined by CTCA in a South
Asian population.
Methods: A retrospective study was conducted at The Aga Khan University Hospital. A total of 539 patient records
were reviewed who had undergone CCS and CTCA between 2008 and 2010. Patient records were reviewed by
comparing their CCS and CTCA results.
Results: About 268 out of 301 (89%) patients with a CCS of 0–9 were found to be free of stenosis on CTCA. On a
CCS of 10–99, 110 out of 121 (91%) patients were either free of stenosis or had mild stenosis. About 66 out of 79
(84%) patients had moderate or severe stenosis with a calcium score of 100–400 while none of the patients were
free of stenosis. Around 28 out of 38 (74%) patients with a CCS of more than 400 had severe stenosis. However,
only 04 patients (11%) were found to have mild stenosis. Spearman’s rho revealed a correlation coefficient of 0.791
with a p-value of <0.001.
Conclusion: Our study reaffirms that in South Asian population, low CCS (<100) is associated with no or minimal
stenosis while high CCS warrants further investigation; hence, making it a reliable tool for screening patients with
CAD.
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Background
South Asian population is regarded as one of the most
susceptible populations to coronary artery disease (CAD)
[1]. Already an important cause of morbidity and mortality
in developed countries, CAD has started taking its toll on
developing countries as well. Mohan et al. reported an
overall prevalence of 11% of CAD in a native urban South
Indian population whereas Jafar et al. reported around
27% people to be suffering from CAD in Karachi, Pakistan
[2,3]. This necessitates the development of better tech-
niques for evaluation of the disease that are feasible with
minimal invasiveness and side effects, in order to facilitate
early interventions.
Recent progress in imaging techniques has given us
the liberty to assess the development and progression of
CAD. The advent of computed tomography coronary
angiography (CTCA) has increased our knowledge re-
garding the pathophysiology of CAD [4]. It is a benefi-
cial, non-invasive technique that promises a high degree
of accuracy in ruling out CAD. With high feasibility and
little procedural risk, CTCA represents a reliable and
swift method of directly identifying the extent and sever-
ity of coronary artery stenosis [5,6]. Visualization and
evaluation of the coronary artery anatomy, morphology
and lesions have been made more convenient by this
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technique with the help of a higher temporal and spatial
resolution [4]. Though it may not provide the degree of
image quality and diagnostic accuracy compared to in-
vasive coronary angiography, its sensitivity and specifi-
city of 97.4% and 97.8%, respectively with positive
predictive value and negative predictive value of 92.2%
and 100%, respectively along with a diagnostic accuracy
of 96.5% is impressive [7].
Another imaging modality, coronary calcium scoring
(CCS) may serve as a strong indicator of cardiac patho-
logical processes such as atherosclerosis which can be
measured either by fast electron beam computed tomog-
raphy (EBCT) or multi-detector computerized tomog-
raphy (MDCT) [8]. It provides an indication of coronary
plaque load and allows risk stratification in patients [9].
Such has been its impact that it has been regarded to be
more sensitive and specific in estimating the risk of
coronary events than the conventional Framingham risk
score [10]. Moreover, a study found a progressive in-
crease in the adjusted risk score of coronary events with
simultaneous increase in calcium score in four racial
groups [11].
CCS is a relatively cheaper modality with decreased
exposure to radiation as compared to CTCA. Hence, it
could be used as a more feasible screening tool in pa-
tients with CAD. However, data comparing the extent to
which the results of CTCA and CCS complement each
other remain scarce in the South Asian population. We
aimed to evaluate the accuracy of CCS in determining the
degree of stenosis of coronary vessels as compared to that
determined by CTCA in a South Asian population.
Methods
The study was carried out at the Department of Radiology,
The Aga Khan University Hospital (AKUH), Karachi.
AKUH is a major tertiary care hospital serving more
than 10 million people of Karachi and the surrounding
region. With an operational strength of 650 beds, the
facility serves over 42,000 inpatients and over 500,000
outpatients annually. Established since 1985, it is one
of the few teaching hospitals in South Asia accredited
by the Joint Commission for International Accredit-
ation [12]. A retrospective study design was conducted
in which the medical record numbers of patients who
had undergone CTCA and CCS were obtained.
Inclusion and exclusion criteria
All the patients undergoing both CTCA and CCS
between February 2008 and February 2010 were included
in the study. No patients were excluded.
Scans for the procedures had been acquired on a
Toshiba Aquilion 64-row detector computerized tomog-
raphy scanner (Toshiba Medical Systems, Japan) using
cardiac gating. All the scans were read by two professional
radiologists separately and the final result was docu-
mented. The procedures were carried out as below:
Coronary calcium score
After obtaining informed consent, a non contrast scan
extending from the pulmonary hilum to the base of the
heart was obtained in a single breath hold. Volume data
was reconstructed in 3 mm axial images. This data was
then transferred to a Vitrea 2 Workstation (Vital Images,
USA). The coronary artery calcium was manually tagged.
The calcium score was calculated using the Agaston sys-
tem of scoring [13].
Computed tomography coronary angiography
The indications for CTCA included presence of chest
pain and risk factors for CAD, positive (or equivocal)
stress test, preoperative assessment prior to valve surgery,
evaluation for cardiomyopathy and screening for CAD.
After obtaining informed consent, the patients’ renal
function were pre-assessed by serum creatinine levels
and they were asked to abstain from caffeine, tobacco
and other stimulants for 24 hours prior to the scan. The
patients were pre-treated with an oral beta-blocker;
Metoprolol 50 mg 12 hours and 2 hours prior to the
scan while calcium channel blockers were substituted if
there were any standard beta-blocker contraindications
to target an optimal heart rate for the scans in the range
of 55–65 beats per minute. Intra venous access was
obtained in the ante-cubital fossa with a 20G cannula.
80 mLs of non-ionic contrast containing 350 mg of
Iodine/mL was injected at a rate of 4 mLs/sec followed
by 40 mLs of normal saline. Scan was obtained in single
breath hold from the pulmonary hilum to the base of
the heart. The data was retrospectively gated and
reconstructed at 70, 80 and 30% of the RR interval.
Further reconstructions were carried out as required to
assess individual segments. Data was transferred to a
Vitrea 2 workstation (Vital Images USA) for analysis.
Age, gender, degree of coronary stenosis as obtained
through the CTCA and calcium score of the subject as
obtained from the CCS were acquired from the records.
The classification of degree of stenosis was as follows;
mild <30%, moderate 30-60% and severe > 60%. Risk
factors for developing CAD like smoking, fasting lipid
levels, family history of CAD etc. were not evaluated.
The data was entered and analyzed using Statistical
package for social science (SPSS 19.0 copyright © SPSS;
1989–02). Descriptive analysis was carried out for the
data. The degree of stenosis was divided into four
groups namely i) free of stenosis ii) mild iii) moderate
and iv) severe, whereas calcium scores were divided
into ranges of i) 0–9 ii) 10–99 iii) 100–400 and iv) > 400.
As the data was non parametric, Spearman’s rho was
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performed to assess the correlation between the degree of
stenosis and calcium scores.
Ethical approval
Due to the retrospective nature of the study, a written
informed consent could not be obtained from the partic-
ipants. However, identification of the study participants
was kept strictly confidential and approval was taken by
the Ethics Review Committee of the Aga Khan University
Hospital prior to commencement of the study.
Results
A total of 539 patients were reviewed retrospectively.
The mean age was 50.8 ± 10.3 years, 389 (72%) patients
were males (Table 1).
Calcium score at different levels of the degree of stenosis
It was found that 268 (89%) out of 301 patients with a
calcium score of 0–9 were free of stenosis on CTCA
while only 8% had moderate to severe stenosis.
In patients with a calcium score of 10–99, majority
(91%) were either free of stenosis or had mild stenosis.
The remaining patients had either moderate or severe
stenosis.
In patients with calcium score between 100–400, more
than half of the patients; 55% had moderate stenosis
while none of the patients were free of stenosis. How-
ever, about 29% of the patients were affected with severe
stenosis.
In patients with a calcium score of > 400, approxi-
mately three quarters of them (74%) had severe stenosis.
However, only 11% of patients were found to have mild
stenosis. Table 2 summarizes the frequency analysis be-
tween calcium scores and degree of stenosis. Spearman’s
rho revealed a correlation coefficient of 0.791 with a
p-value of < 0.001.
Discussion
Advances in the imaging modalities in the last decades
have raised the expectations of patients to have access to
simpler and non-invasive techniques to reach a diagno-
sis. CTCA is being increasingly used as both, a screening
and a diagnostic modality whereas CCS is mainly used
for the purpose of risk stratification. CCS is highly cost
effective and if accurate in predicting the degree of sten-
osis, may reduce the number of patients referred for
diagnostic procedures lowering the cost burden. Hence,
there was a need to compare CTCA and CCS as screen-
ing modalities.
CTCA is a non-invasive radiological procedure that al-
lows obtaining quick images with a higher temporal and
spatial resolution. It allows direct visualization and
evaluation of the coronary artery anatomy, morphology
and any lesions within [4]. Moreover, a high degree of
accuracy has been validated in identifying the extent
and severity of coronary artery stenosis [7]. CCS, on the
other hand is an established marker for atherosclerosis
and a predictor of cardiac events. It is used to locate and
quantify coronary artery calcification [9,14]. A higher
score predicts higher plaque burden and a greater chance
of cardiac events. CCS is better suited to identify patients
with disease rather than to rule out disease or to localize it
to particular arterial segments [15] while diagnostically,
CTCA’s supremacy has been proven in ruling out disease
where CCS has been proven to be inadequate [16,17].
Table 1 Frequency analysis of patients undergoing
computed tomography coronary angiography and
coronary calcium scoring
Degree of stenosis on computed tomography
coronary angiography
Number of patients
(%)
Free of stenosis 289 (54)
Mild 116 (21)
Moderate 65 (12)
Severe 69 (13)
Coronary Calcium Score
0-9 301 (56)
10-99 121 (22)
100-400 79 (15)
>400 38 (7)
Table 2 Frequency analysis showing the comparison
between the degree of stenosis and groups of coronary
calcium scoring
Calcium score Degree of stenosis Number of patients (%)
0-9 Free of stenosis 268(89.0)
Mild 10(3.3)
Moderate 7(2.3)
Severe 16(5.3)
Total 301(100)
10-99 Free of stenosis 21(17.4)
Mild 89(73.6)
Moderate 9(7.4)
Severe 2(1.7)
Total 121(100)
100-400 Mild 13(16.5)
Moderate 43(54.4)
Severe 23(29.1)
Total 79(100)
>400 Mild 4(10.5)
Moderate 6(15.8)
Severe 28(73.7)
Total 38(100)
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CTCA, however, is a modality which is not free of risks.
High doses of X-ray radiations particularly in women and
young patients are a serious concern which could lead to
serious long-term effects [18]. Keeping the adverse effects
in mind, it has been reported that due to low probability
in finding non-calcified plaques in the subgroup of
negative CCS, CTCA might not always be justified [19].
Keeping this in mind, modalities with fewer side effects
like CCS must be brought into practice and justified to
screen for CAD; which paved way for this study. The
main outcome of this study suggests that increasing
CCS correlates with the severity of CAD. However, it
also confirms that the extremes of CCS do not necessarily
rule out or rule in severe CAD.
In the present study, CTCA showed 89% of the
patients to be free of stenosis with a CCS of 0–9. This is
consistent with the studies carried out by Werkhoven
et. al and Lau et. al who reported 80% and 84% of the
patients having no stenosis with a CCS of 0 respectively
[15,20]. However, around 5% of our patients in this sub
group had severe stenosis. Werkhoven et.al observed
significant CAD in 4% of patients with a CCS of 0 com-
pared to 8% detected by Cademartiri et al. and Akram
et al. [16,20,21]. Presence of stenosis in the absence of
CCS is due to early atherosclerosis which contains
lipid-rich plaques which have not calcified. These plaques
are proven to be more susceptible to rupture as compared
to relatively stable calcium plaques [22,23] making it
essential to diagnose and locate them as early as
possible. Having said that, histological analysis remains
superior to all other modalities [15]. However, its utility
in clinical practice remains limited.
In the present study, CCS between 10 and 99 was
highly associated with either no or mild stenosis. The
intermediate CCSs, on the other hand were less conclu-
sive. Although 54% of the patients with 100–400 CCS
had moderate stenosis, 29% had severe disease. Leber,
in one of his reviews, mentioned that scores that fall in
the intermediate percentiles are not statistically significant
[24]. On the other extreme of CCS of > 400; however,
the percentage of severe stenosis was the highest at
73.7%. This association, between a high CCS and in-
creased severity in stenosis, is corresponding to the
literature which suggests that there is a significantly
higher chance of cardiac events in this subgroup of
patients [11,15,19,25]. Lau et. al reported that a CCS
greater than or equal to 400 increased the sensitivity of
CTCA from 93% to 100% [15]. Hence, it may help diag-
nose disease that is not detected at CT angiography.
A factor which cannot be ignored particularly in the
developing countries like Pakistan, is cost effectiveness
and patient’s feasibility, hence the need of better applica-
tion of CCS as a screening modality if CTCA could not
be afforded by the patient.
Limitations
Some limitations of the study need to be addressed.
Firstly, there were an unequal number of patients in
different groups stratified on the basis of CCS. However,
this difference was inherent in this study being a retro-
spective analysis of the hospital data. Secondly, our study
did not take into account the demographics and other
risk factors which define the cardiovascular profile of
the patients. This also was not that relevant to the study
question and; therefore, a more comprehensive study
can be designed which can include the above with the
screening modalities. This would enable a risk score
based on these risk factors along with CCS to be gener-
ated for the South Asian population on the lines of the
Framingham risk score, which would further help in risk
stratification of patients with suspected CAD. Thirdly,
this study was not designed to calculate the sensitivity,
specificity and positive and negative predictive values for
CCS. Lastly, we compared CCS as a screening modality
to CTCA and not the invasive coronary angiography
which is considered the gold standard for diagnosing
CAD.
Conclusion
The complementary use of CTCA and CCS provides an
optimal diagnosis in stenosis detection. A rise in CCS
levels simultaneously raises the probability of significant
CAD and presents a good and feasible alternative screen-
ing modality. It is also emphasized that absence of CCS
does not necessarily rule out a disease and vice versa.
Our study reaffirms in the South Asian population that
low CCS (<100 in our study) is highly indicative of no
or minimal stenosis. In this subgroup, further workup
should only be carried out in high risk patients. On the
other hand, a high CCS in most cases warrants further
investigations such as CTCA or invasive coronary angi-
ography to reach a confirmatory diagnosis.
Competing interest
The authors have no financial or other competing interests to declare.
Authors’ contributions
NB: Conception, design and drafting of manuscript. AK: Drafting of
manuscript and data collection. AJ: Analysis, Interpretation and acquisition of
data. MB: Analysis and interpretation of data. RE: Critical Revision and Gave
Final Approval. ZS: Conception, Critical review, added intellectual content. All
authors read and approved the final manuscript.
Author details
1Department of Medicine, Research Associate, Aga Khan University, Karachi,
Pakistan. 2Medical College, Aga Khan University, Karachi, Pakistan.
3Department of Biological and Biomedical, Sciences, Teaching Assistant, Aga
Khan University, Karachi, Pakistan. 4Department of Medicine, Division of
Cardiology, University of California Los Angeles, Los Angeles, California, USA.
5Department of Radiology, Associate Professor and Chair, Aga Khan
University Hospital, Karachi, Pakistan.
Received: 8 December 2012 Accepted: 18 July 2013
Published: 19 July 2013
Bhulani et al. BMC Research Notes 2013, 6:279 Page 4 of 5
http://www.biomedcentral.com/1756-0500/6/279
References
1. Iqbal MP: Hyperhomocysteinemia and coronary artery disease in
Pakistan. J Pak Med Assoc 2006, 56:282–5.
2. Jafar TH, Jafary FH, Jessani S, Chaturvedi N: Heart disease epidemic in
Pakistan: women and men at equal risk. Am Heart J 2005, 150:221–6.
3. Mohan V, Deepa R, Rani SS, Premalatha G: Prevalence of coronary artery
disease and its relationship to lipids in a selected population in South
India: the Chennai Urban population study (CUPS No. 5). J Am Coll
Cardiol 2001, 38:682–7.
4. Gaemperli O, Husmann L, Schepis T, Koepfli P, Valenta I, Jenni W, Alkadhi H,
Lüscher TF, Kaufmann PA: Coronary CT angiography and myocardial
perfusion imaging to detect flow-limiting stenoses: a potential
gatekeeper for coronary revascularization? Eur Heart J 2009, 30:2921–9.
5. Bowman AW, Kantor B, Gerber TC: Coronary computed tomographic
angiography: current role in the diagnosis and management of coronary
artery disease. Pol Arch Med Wewn 2009, 119:381–90.
6. Tamarappoo BK, Gutstein A, Cheng VY, Nakazato R, Gransar H, Dey D,
Thomson LE, Hayes SW, Friedman JD, Germano G, Slomka PJ, Berman DS:
Assessment of the relationship between stenosis severity and
distribution of coronary artery stenoses on multislice computed
tomographic angiography and myocardial ischemia detected by single
photon emission computed tomography. J Nucl Cardiol 2010, 17:791–802.
7. Xu Y, Tang L, Zhu X, Xu H, Tang J, Yang Z, Wang L, Wang D: Comparison
of dual-source CT coronary angiography and conventional coronary
angiography for detecting coronary artery disease. Int J Cardiovasc
Imaging 2010, 26(Suppl 1):75–81.
8. Elkeles RS: Coronary artery calcium and cardiovascular risk in diabetes.
Atherosclerosis 2010, 210:331–6.
9. Law YM, Huang J, Chen K, Cheah FK, Chua T: Prevalence of significant
extracoronary findings on multislice CT coronary angiography
examinations and coronary artery calcium scoring examinations. J Med
Imaging Radiat Oncol 2008, 52:49–56.
10. Johnson KM, Dowe DA: The detection of any coronary calcium
outperforms Framingham risk score as a first step in screening for
coronary atherosclerosis. AJR Am J Roentgenol 2010, 194:1235–43.
11. Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, Liu K, Shea S,
Szklo M, Bluemke DA, O'Leary DH, Tracy R, Watson K, Wong ND,
Kronmal RA: Coronary calcium as a predictor of coronary events in four
racial or ethnic groups. N Engl J Med 2008, 358:1336–45.
12. Khawaja A, Zubairi AB, Durrani FK, Zafar A: Etiology and outcome of severe
community acquired pneumonia in immunocompetent adults.
BMC Infect Dis 2013, 13:94.
13. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R:
Quantification of coronary artery calcium using ultrafast computed
tomography. J Am Coll Cardiol 1990, 15:827–32.
14. Wexler L, Brundage B, Crouse J, Detrano R, Fuster V, Maddahi J,
Rumberger J, Stanford W, White R, Taubert K: Coronary artery calcification:
pathophysiology, epidemiology, imaging methods, and clinical
implications: a statement for health professionals from the American
heart association: writing group. Circulation 1996, 94:1175–92.
15. Lau GT, Ridley LJ, Schieb MC, Brieger DB, Freedman SB, Wong LA, Lo SK,
Kritharides L: Coronary artery stenoses: detection with calcium scoring,
CT angiography, and both methods combined. Radiology 2005,
235:415–22.
16. Cademartiri F, Maffei E, Palumbo A, Seitun S, Martini C, Tedeschi C, La Grutta
L, Midiri M, Weustink AC, Mollet NR, Krestin GP: Coronary calcium score
and computed tomography coronary angiography in high-risk
asymptomatic subjects: assessment of diagnostic accuracy and
prevalence of non-obstructive coronary artery disease.
Eur Radiol 2010, 20:846–54.
17. Kelly JL, Thickman D, Abramson SD, Chen PR, Smazal SF, Fleishman MJ,
Lingam SC: Coronary CT angiography findings in patients without
coronary calcification. AJR Am J Roentgenol 2008, 191:50–5.
18. Einstein AJ, Henzlova MJ, Rajagopalan S: Estimating risk of cancer
associated with radiation exposure from 64-slice computed tomography
coronary angiography. JAMA 2007, 298:317–23.
19. Venkatesh V, Ellins ML, Yang S, Natarajan M, Amlani S, Sheth T: Incremental
detection of coronary artery disease by assessment of non-calcified
plaque on coronary CT angiography. Clin Radiol 2009, 64:250–5.
20. van Werkhoven JM, Schuijf JD, Gaemperli O, Jukema JW, Kroft LJ, Boersma E,
Pazhenkottil A, Valenta I, Pundziute G, de Roos A, van der Wall EE, Kaufmann
PA, Bax JJ: Incremental prognostic value of multi-slice computed
tomography coronary angiography over coronary artery calcium scoring in
patients with suspected coronary artery disease. Eur Heart J 2009, 30:2622–9.
21. Akram K, O'Donnell RE, King S, Superko HR, Agatston A, Voros S: Influence of
symptomatic status on the prevalence of obstructive coronary artery
disease in patients with zero calcium score. Atherosclerosis 2009, 203:533–7.
22. Cheng GC, Loree HM, Kamm RD, Fishbein MC, Lee RT: Distribution of
circumferential stress in ruptured and stable atherosclerotic lesions. A
structural analysis with histopathological correlation. Circulation 1993,
87:1179–87.
23. Schmermund A, Erbel R: Unstable coronary plaque and its relation to
coronary calcium. Circulation 2001, 104:1682–7.
24. Leber AW: Complementary use of coronary calcium scoring and CT
angiography. Humana Press: CT of the Heart; 2005:333–7.
25. Meijs MF, Meijboom WB, Prokop M, Mollet NR, van Mieghem CA,
Doevendans PA, de Feyter PJ, Cramer MJ: Is there a role for CT coronary
angiography in patients with symptomatic angina? Effect of coronary
calcium score on identification of stenosis. Int J Cardiovasc Imaging 2009,
25:847–54.
doi:10.1186/1756-0500-6-279
Cite this article as: Bhulani et al.: Coronary calcium scoring: are the results
comparable to computed tomography coronary angiography for
screening coronary artery disease in a South Asian population?. BMC
Research Notes 2013 6:279.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Bhulani et al. BMC Research Notes 2013, 6:279 Page 5 of 5
http://www.biomedcentral.com/1756-0500/6/279
